Skip to main content
SpringerLink
Log in

Nootrop wirkende Substanzen

  • Chapter
1×1 der Psychopharmaka

  • 21 Accesses

Zusammenfassung

Die Alzheimer-Krankheit ist die häufigste geriatrische Krankheit. 5% der über 65jährigen leiden daran. Diese Zahl steigt rapide mit dem Lebensalter an, und bei den über 80jährigen sind es schon über 10 bis 20%. Allerdings kann die Krankheit schon bei 35jährigen beginnen.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • American Psychiatric Association (1995) 148th Annual Meeting. Topic 8: Organic Mental Disorders

    Google Scholar 

  • Bloom FE, Kupfer DJ (Hrsg.) (1995) Psychopharmacology. The Fourth Generation in Progress; Geriatric Disorders: 1361–1479; Raven, NY

    Google Scholar 

  • Clark R, Goate A (1993) Molecular genetics of Alzheimer’s disease. Arch Neurol 50: 1164–1172

    Article  PubMed  CAS  Google Scholar 

  • Cohen RM, Weingartner HW, Smallberg A, Pickar D, Murphy DL (1982) Effort and cognition in depression. Arch Gen Psychiatry 39: 593–597

    Article  PubMed  CAS  Google Scholar 

  • Davis KL, Thal LJ, Gamzu E (1992) Tacrine in patients with Alzheimer’s disease: a double blind placebo controlled multicenter study. N Engl J Med 327: 1374–1379

    Article  Google Scholar 

  • Hitzenberger G, Rameis H, Manigley C (1998) Pharmacological Properties of Pirace-tam. CNS Drugs, 9 suppl 1: 19–27

    Article  Google Scholar 

  • Freeman TW, Clothier JL, Pazzaglia P (1992) A Double-blind Comparison of Val-proate and Lithium in the Treatment of Acute Mania. Am J Psychiatry 149: 108–111

    PubMed  CAS  Google Scholar 

  • Mohs RC (1991) Assessment of cognitive symptoms in clinical studies of antidementia drugs (Homma A. trans): Jpn J Geriatr Psychiatry 2: 1195–1201

    Google Scholar 

  • Pierpaoli W, Regelson W, Fabris N (Hrsg.) (1994) The Aging Clock; Ann NY Acad Sci 719

    Google Scholar 

  • Rapoport SI, Grady CL (1993) Parametric in vivo brain imaging during activation to examine pathological mechanisms of functional failure in Alzheimer’s disease. J Neurosci 70: 39–56

    CAS  Google Scholar 

  • Sisodia SS, Koo EH, Beyreuther K, Unterbeck A, Price DL (1990) Evidence that ß-amyloid protein in Alzheimer’s disease is not derived by normal processing. Science 248: 492–495

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik für Psychiatrie, Allgemeines Krankenhaus, Seisgasse 9/13, A-1040, Wien, Österreich

    Dr. Margot Schmitz (Universitätsdozent)

Authors
  1. Dr. Margot Schmitz
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 1999 Steinkopff Verlag, Darmstadt

About this chapter

Cite this chapter

Schmitz, M. (1999). Nootrop wirkende Substanzen. In: 1×1 der Psychopharmaka. Steinkopff, Heidelberg. https://doi.org/10.1007/978-3-642-53728-8_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-53728-8_7

  • Publisher Name: Steinkopff, Heidelberg

  • Print ISBN: 978-3-7985-1198-9

  • Online ISBN: 978-3-642-53728-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation